Buy Rating Affirmed for Verona Pharma Amid Strategic Partnership and Market Potential for Novel COPD Treatment

TipRanksSep 17 21:45 · Ratings

Verona Pharma And Ritedose Partner To Deliver First-In-Class COPD Drug, Ohtuvayre

BenzingaSep 17 20:31

President Of Verona Pharma Sold 28% Of Their Shares

Simply Wall StSep 16 18:13

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

InvestingSep 14 07:52

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

InvestingSep 14 07:51

New Additions to Roth MKM's ADR Portfolio for September

Seeking AlphaSep 12 22:41